Follow The Filings

AMGN Amgen

Health Care, filed as AMGEN INC (COM), Equity As of 2026 Q3 among managers we track Quote on Google Finance, opens in a new tab

Bought by 1 manager in 2026 Q2

  • 3 Owners
  • #295
  • Max 3.1%
  • Master 0.00%
  • $60M
  • 3 reduce

In 2026 Q3 Torray Investment Partners, David Katz, and Kentucky Trust trimmed Amgen.

Who owns this now

Largest portfolio weights among holders, up to 3.1% (Torray Investment Partners). Not free-float ownership.

  1. Torray Investment Partners Reduce 3.1%
  2. David Katz Reduce 2.9%
  3. Kentucky Trust Co. Reduce 0.93%

Who owns AMGN

Sorted by value, long equity only, as of 2026 Q3.

History
David Katz, Matrix Asset Advisors 2.9%, was 3.0% Reduce −18.4% 83,919 $35M History
Torray Investment Partners 3.1% Reduce −7.8% 55,136 $23M History
Kentucky Trust Co., Kentucky Trust 0.93% Reduce −6.4% 4,415 $1.9M History

3 current, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by AMGN's executives, directors and 10% owners in the last 12 months, from their Form 4s

All AMGN insider trades
  • None no insider bought on the open market
  • $8.2M sold by 4 insiders outside a trading plan
  • None no planned (10b5-1) sales
  1. Rachna Khosla SVP, Business Development
    Sale
    $1.3M 3,252 shares at $414.05 34% of stake
    Traded Aug 11–13 Filed Aug 13
    ↗
  2. Derek Miller SVP, Human Resources
    Sale
    $1.6M 3,890 shares at $402.54 24% of stake
    Traded Aug 6 Filed Aug 7
    ↗
  3. Nancy A. Grygiel SVP & CCO
    Sale
    $1.2M 2,970 shares at $402.16 29% of stake
    Traded Aug 6 Filed Aug 7
    ↗
  4. Nancy A. Grygiel SVP & CCO
    Sale
    $400K 1,237 shares at $323.73 15% of stake
    Traded May 4 Filed May 5
    ↗
  5. Nancy A. Grygiel SVP & CCO
    Sale
    $1.1M 3,139 shares at $337.26 30% of stake
    Traded Nov 20, 2025 Filed Nov 21, 2025
    ↗
  6. Rachna Khosla SVP, Business Development
    Sale
    $299K 890 shares at $336.24 11% of stake
    Traded Nov 12, 2025 Filed Nov 13, 2025
    ↗
  7. Murdo Gordon EVP, Global Commercial Ops
    Sale
    $2.3M 6,879 shares at $336.83 14% of stake
    Traded Nov 12, 2025 Filed Nov 13, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 54 share withholdings for taxes, 32 stock grants, 7 option exercises, and 2 gifts.

Congress

18 members of Congress traded AMGN in the last three years: 21 buys and 20 sales. 24 members listed it in 2025 annual reports.

All Congress trades
  1. David J. Taylor R-OH-2 Buy $1K–$15K Sep 22 filed Oct 1
  2. David J. Taylor R-OH-2 Sell $1K–$15K Aug 26 filed Sep 5
  3. David J. Taylor R-OH-2 Sell $1K–$15K Aug 26 filed Sep 5
  4. Sheldon Whitehouse D-RISpouse Partial sale $1K–$15K Aug 12 filed Sep 2
  5. Alan Armstrong R-OK Sell $15K–$50K Mar 27 filed Jul 21
  6. David J. Taylor R-OH-2 Buy $1K–$15K Jun 5 filed Jun 12

SEC filings

Recent issuer filings from EDGAR, 7 shown.

Filed Form Detail Links
8-K 5.02 Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 1.05 Filing Doc
8-K 5.07 Filing Doc
8-K 5.02 Filing Doc
SCHEDULE 13G — Filing Doc

Source: SEC EDGAR submissions, updated 3 days ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue $28.19B $33.42B $36.75B
Gross profit * $19.74B $20.57B $24.71B
Gross margin * 70.0% 61.5% 67.2%
Net income $6.72B $4.09B $7.71B
Net margin * 23.8% 12.2% 21.0%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $30.33B $29.03B $29.06B
Total non-current assets * $66.82B $62.81B $61.53B
Total assets $97.15B $91.84B $90.59B
Total current liabilities $18.39B $23.1B $25.49B
Total equity $6.23B $5.88B $8.66B

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $8.47B $11.49B $9.96B
Cash from investing -$26.2B -$1.05B -$1.94B
Cash from financing $21.05B -$9.42B -$10.86B
Net change in cash $3.32B $1.03B -$2.84B

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.